Fort Washington Investment Advisors Inc. OH Lowers Stake in Encompass Health Corporation $EHC

Key Points

• Fort Washington Investment Advisors Inc. OH reduced its stake in Encompass Health Corporation by 28.0%, owning 216,676 shares valued at approximately $26.57 million after selling 84,346 shares in the second quarter.
• Encompass Health recently announced a quarterly dividend increase to $0.19 per share, resulting in a 0.6% yield, and will be paid on October 15th.
• Recent analyst reports have led to several price target increases for Encompass Health, with an average target of $138.43 and a consensus rating of "Buy."

Fort Washington Investment Advisors Inc. OH lowered its stake in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 28.0% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 216,676 shares of the company's stock after selling 84,346 shares during the period. Fort Washington Investment Advisors Inc. OH owned approximately 0.21% of Encompass Health worth $26,571,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in the stock. Signaturefd LLC boosted its position in shares of Encompass Health by 29.1% during the 2nd quarter. Signaturefd LLC now owns 869 shares of the company's stock worth $107,000 after purchasing an additional 196 shares during the period. Congress Asset Management Co. purchased a new position in shares of Encompass Health during the 2nd quarter worth approximately $92,691,000. Dakota Wealth Management purchased a new position in shares of Encompass Health during the 2nd quarter worth approximately $317,000. Retirement Guys Formula LLC purchased a new position in Encompass Health in the 2nd quarter valued at approximately $207,000. Finally, TD Private Client Wealth LLC boosted its position in Encompass Health by 165.1% in the 2nd quarter. TD Private Client Wealth LLC now owns 8,125 shares of the company's stock valued at $996,000 after buying an additional 5,060 shares during the period. Hedge funds and other institutional investors own 97.25% of the company's stock.

Insider Buying and Selling

In related news, EVP Patrick William Tuer sold 1,020 shares of Encompass Health stock in a transaction on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total transaction of $126,061.80. Following the sale, the executive vice president directly owned 18,846 shares in the company, valued at $2,329,177.14. This trade represents a 5.13% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 2.10% of the stock is owned by corporate insiders.

Encompass Health Price Performance

Shares of EHC opened at $126.78 on Monday. Encompass Health Corporation has a twelve month low of $87.85 and a twelve month high of $127.86. The firm's fifty day simple moving average is $119.60 and its 200-day simple moving average is $114.84. The firm has a market capitalization of $12.77 billion, a price-to-earnings ratio of 24.81, a PEG ratio of 2.22 and a beta of 0.92. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.76.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings data on Monday, August 4th. The company reported $1.40 earnings per share for the quarter, beating analysts' consensus estimates of $1.20 by $0.20. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. The business had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.43 billion. During the same period last year, the business earned $1.11 EPS. The company's revenue was up 12.0% on a year-over-year basis. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. Equities analysts forecast that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be paid a dividend of $0.19 per share. The ex-dividend date is Wednesday, October 1st. This represents a $0.76 annualized dividend and a yield of 0.6%. This is an increase from Encompass Health's previous quarterly dividend of $0.17. Encompass Health's dividend payout ratio (DPR) is 13.31%.

Analysts Set New Price Targets

EHC has been the subject of several recent research reports. UBS Group raised their price target on shares of Encompass Health from $130.00 to $140.00 and gave the company a "buy" rating in a research report on Wednesday, August 6th. Truist Financial raised their price target on shares of Encompass Health from $135.00 to $140.00 and gave the company a "buy" rating in a research report on Thursday, August 14th. Wall Street Zen cut shares of Encompass Health from a "strong-buy" rating to a "buy" rating in a research report on Friday, June 6th. Bank of America raised their price target on shares of Encompass Health from $145.00 to $160.00 and gave the company a "buy" rating in a research report on Wednesday, September 10th. Finally, KeyCorp raised their price target on shares of Encompass Health from $135.00 to $140.00 and gave the company an "overweight" rating in a research report on Tuesday, September 16th. One research analyst has rated the stock with a Strong Buy rating and seven have given a Buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Buy" and an average price target of $138.43.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.